222 related articles for article (PubMed ID: 29780153)
1. Food-specific IgGs Are Highly Increased in the Sera of Patients with Inflammatory Bowel Disease and Are Clinically Relevant to the Pathogenesis.
Xiao N; Liu F; Zhou G; Sun M; Ai F; Liu Z
Intern Med; 2018 Oct; 57(19):2787-2798. PubMed ID: 29780153
[TBL] [Abstract][Full Text] [Related]
2. Serological investigation of IgG and IgE antibodies against food antigens in patients with inflammatory bowel disease.
Wang HY; Li Y; Li JJ; Jiao CH; Zhao XJ; Li XT; Lu MJ; Mao XQ; Zhang HJ
World J Clin Cases; 2019 Aug; 7(16):2189-2203. PubMed ID: 31531314
[TBL] [Abstract][Full Text] [Related]
3. Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy.
Caneparo V; Pastorelli L; Pisani LF; Bruni B; Prodam F; Boldorini R; Roggenbuck D; Vecchi M; Landolfo S; Gariglio M; De Andrea M
Inflamm Bowel Dis; 2016 Dec; 22(12):2977-2987. PubMed ID: 27636380
[TBL] [Abstract][Full Text] [Related]
4. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
[TBL] [Abstract][Full Text] [Related]
5. Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia.
Zuo XL; Li YQ; Li WJ; Guo YT; Lu XF; Li JM; Desmond PV
Clin Exp Allergy; 2007 Jun; 37(6):823-30. PubMed ID: 17517095
[TBL] [Abstract][Full Text] [Related]
6. Serum IgE and IgG responses to food antigens in normal and atopic dogs, and dogs with gastrointestinal disease.
Foster AP; Knowles TG; Moore AH; Cousins PD; Day MJ; Hall EJ
Vet Immunol Immunopathol; 2003 May; 92(3-4):113-24. PubMed ID: 12730012
[TBL] [Abstract][Full Text] [Related]
7. IgE/anti-IgE immune complexes in sera from patients with Crohn's disease do not contain food-specific IgE.
Huber A; Genser D; Spitzauer S; Scheiner O; Jensen-Jarolim E
Int Arch Allergy Immunol; 1998 Jan; 115(1):67-72. PubMed ID: 9430498
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin G4-related immune responses to common food antigens in patients with ulcerative colitis and Crohn's disease.
Sub Lee H; Jae Lee K
Turk J Gastroenterol; 2019 May; 30(5):408–414. PubMed ID: 31060995
[TBL] [Abstract][Full Text] [Related]
9. Serological investigation of food specific immunoglobulin G antibodies in patients with inflammatory bowel diseases.
Cai C; Shen J; Zhao D; Qiao Y; Xu A; Jin S; Ran Z; Zheng Q
PLoS One; 2014; 9(11):e112154. PubMed ID: 25393003
[TBL] [Abstract][Full Text] [Related]
10. Serum IgE levels in patients with inflammatory bowel disease.
Levo Y; Shalit M; Wollner S; Fich A
Ann Allergy; 1986 Jan; 56(1):85-7. PubMed ID: 3946842
[TBL] [Abstract][Full Text] [Related]
11. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases.
Frehn L; Jansen A; Bennek E; Mandic AD; Temizel I; Tischendorf S; Verdier J; Tacke F; Streetz K; Trautwein C; Sellge G
PLoS One; 2014; 9(9):e106750. PubMed ID: 25215528
[TBL] [Abstract][Full Text] [Related]
12. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
[TBL] [Abstract][Full Text] [Related]
13. α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease.
Manolakis AC; Christodoulidis G; Kapsoritakis AN; Georgoulias P; Tiaka EK; Oikonomou K; Valotassiou VJ; Potamianos SP
World J Gastroenterol; 2017 Jan; 23(3):437-446. PubMed ID: 28210079
[TBL] [Abstract][Full Text] [Related]
14. Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease.
Bjerrum JT; Steenholdt C; Ainsworth M; Nielsen OH; Reed MA; Atkins K; Günther UL; Hao F; Wang Y
BMC Med; 2017 Oct; 15(1):184. PubMed ID: 29032767
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
[TBL] [Abstract][Full Text] [Related]
16. Anti-food and anti-microbial IgG subclass antibodies in inflammatory bowel disease.
Jansen A; Mandić AD; Bennek E; Frehn L; Verdier J; Tebrügge I; Lutz H; Streetz K; Trautwein C; Sellge G
Scand J Gastroenterol; 2016 Dec; 51(12):1453-1461. PubMed ID: 27455092
[TBL] [Abstract][Full Text] [Related]
17. Food antigen-induced immune responses in Crohn's disease patients and experimental colitis mice.
Kawaguchi T; Mori M; Saito K; Suga Y; Hashimoto M; Sako M; Yoshimura N; Uo M; Danjo K; Ikenoue Y; Oomura K; Shinozaki J; Mitsui A; Kajiura T; Suzuki M; Takazoe M
J Gastroenterol; 2015 Apr; 50(4):394-405. PubMed ID: 25099432
[TBL] [Abstract][Full Text] [Related]
18. Serum bacterial toxins are related to the progression of inflammatory bowel disease.
Qiu H; Sun X; Sun M; He C; Li Z; Liu Z
Scand J Gastroenterol; 2014 Jul; 49(7):826-33. PubMed ID: 24853095
[TBL] [Abstract][Full Text] [Related]
19. Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatment.
Krajcovicova A; Batovsky M; Gregus M; Hlista M; Durina J; Leskova Z; Sturdik I; Gojdic M; Jalali Y; Koller T; Toth J; Huorka M; Hlavaty T
Acta Gastroenterol Belg; 2018; 81(4):465-470. PubMed ID: 30645913
[TBL] [Abstract][Full Text] [Related]
20. Serum adipokines in inflammatory bowel disease.
Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
